These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31135236)

  • 1. Ocular manifestations in hereditary transthyretin Gly67Glu amyloidosis.
    Leung KCP; Ko TCS
    Amyloid; 2019 Sep; 26(3):171-172. PubMed ID: 31135236
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure.
    Arvanitis M; Chan GG; Jacobson DR; Berk JL; Connors LH; Ruberg FL
    Amyloid; 2017 Dec; 24(4):253-255. PubMed ID: 29052438
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical manifestations in hereditary amyloidosis with the variant Glu54Gln transthyretin.
    Jercan A; Badelita S; Draghici M; Stoica E; Iacob S; Coriu D
    Amyloid; 2019; 26(sup1):31-32. PubMed ID: 31343281
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: a case report.
    Kon T; Misumi Y; Nishijima H; Honda M; Suzuki C; Baba M; Inomata Y; Obayashi K; Ando Y; Tomiyama M
    Amyloid; 2015; 22(3):203-4. PubMed ID: 26123280
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac and peripheral vasomotor autonomic functions in hereditary transthyretin amyloidosis with non-Val30Met mutation.
    Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
    Amyloid; 2019; 26(sup1):13-14. PubMed ID: 31343285
    [No Abstract]   [Full Text] [Related]  

  • 6. Transthyretin amyloidosis in patients with undifferentiated heart failure.
    Chang IC; Scott CG; Dispenzieri A; AbouEzzeddine O; Lin G; Grogan M
    Amyloid; 2019; 26(sup1):33-34. PubMed ID: 31343280
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic angiopathy and axonopathy in hereditary transthyretin amyloidosis with Ala97Gly (p. Ala117Gly) mutation: a post-mortem analysis.
    Koike H; Yasuda T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sobue G; Katsuno M
    Amyloid; 2018 Jun; 25(2):141-142. PubMed ID: 29855203
    [No Abstract]   [Full Text] [Related]  

  • 8. Case report of a young patient with transthyretin amyloidosis associated with Gly67Ala mutation.
    Salihoglu A; Yildirim S; Ar MC; Hancer VS; Bozcan S; Yilmaz U; Serin N; Tuzuner N; Celik AF
    Amyloid; 2019; 26(sup1):75-76. PubMed ID: 31343303
    [No Abstract]   [Full Text] [Related]  

  • 9. Transthyretin amyloidosis: a little history of hereditary amyloidosis.
    Benson MD
    Amyloid; 2017 Mar; 24(sup1):76-77. PubMed ID: 28434305
    [No Abstract]   [Full Text] [Related]  

  • 10. Transthyretin Val122Ile amyloidosis associated with isolated gastrointestinal disease and bowel rupture in a Caucasian woman.
    Sirdesai S; Hosking P; Stewart G; Ting S; Booth D; Fong E; Gibbs SDJ
    Pathology; 2019 Jun; 51(4):436-439. PubMed ID: 31003840
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial amyloidotic polyneuropathy and transthyretin.
    Nagasaka T
    Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of siRNA for removal of transthyretin V30M in a TTR leptomeningeal animal model.
    Gonçalves P; Martins H; Costelha S; Saraiva MJ
    Amyloid; 2017 Mar; 24(sup1):38-39. PubMed ID: 28434297
    [No Abstract]   [Full Text] [Related]  

  • 13. Machine Learning Identifies Plasma Metabolites Associated With Heart Failure in Underrepresented Populations With the
    Park JK; Petrazzini BO; Saha A; Vaid A; Vy HMT; Márquez-Luna C; Chan L; Nadkarni GN; Do R
    J Am Heart Assoc; 2023 Apr; 12(8):e027736. PubMed ID: 37042260
    [No Abstract]   [Full Text] [Related]  

  • 14. Transthyretin Cardiac Amyloidosis Due to Homozygous Val122Ile Mutation in a Caucasian Man.
    Marrero Negrín N; Medina Gil JM; García Cruz ML; Jiménez Cabrera F
    Rev Esp Cardiol (Engl Ed); 2019 Dec; 72(12):1086-1088. PubMed ID: 31561982
    [No Abstract]   [Full Text] [Related]  

  • 15. A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy.
    Huda A; Castaño A; Niyogi A; Schumacher J; Stewart M; Bruno M; Hu M; Ahmad FS; Deo RC; Shah SJ
    Nat Commun; 2021 May; 12(1):2725. PubMed ID: 33976166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreal deposits in Val71Ala transthyretin amyloidosis.
    Suan D; Booth DR; Kennedy IH; Downie J; Earls P; Gottlieb D; Stewart GJ; Lin MW
    Intern Med J; 2012 Jan; 42(1):106-8. PubMed ID: 22276564
    [No Abstract]   [Full Text] [Related]  

  • 17. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
    Coelho T; Maurer MS; Suhr OB
    Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexplained cardiac failure leading to the identification of a Belgian family affected by hereditary amyloidosis.
    De Pasqual A; Biessaux Y; Blettard N; Crémers S; Caers J
    Acta Clin Belg; 2013; 68(4):303-5. PubMed ID: 24455802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation.
    Liu T; Zhang B; Jin X; Wang W; Lee J; Li J; Yuan H; Cheng X
    Eye (Lond); 2014 Jan; 28(1):26-33. PubMed ID: 24113303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transthyretin amyloidosis: a phenocopy of hypertrophic cardiomyopathy.
    Vermeer AMC; Janssen A; Boorsma PC; Mannens MMAM; Wilde AAM; Christiaans I
    Amyloid; 2017 Jun; 24(2):87-91. PubMed ID: 28475415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.